Abstract
Neuromyelitis optica (NMO) is an immune-mediated condition of the CNS preferentially involving spinal cord and optic nerves. Serum autoantibodies targeting aquaporin-4 (AQP4) are diagnostic markers of NMO.
Within 5 years from onset, 50 % of patients with relapsing NMO are blind in one or both eyes, and/or need assistance to walk, and/or use a wheelchair.
Most patients with AQP4-IgG positive NMO have a severe, relapsing course.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol. 2007;6:805–15.
Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66:1485–9.
Pittock SJ(a), Lennon VA, Wingerchuk DM, et al. Brain abnormalities in neuromyelitis optica. Arch Neurol. 2006;63:390–6.
Jarius S, Wildemann B, Paul F. Neuromyelitis optica: clinical features, immunopathogenesis and treatment. Clin Exp Immunol. 2014;176:149–64.
Jiao Y, Fryer JP, Lennon VA, et al. Aquaporin 4 IgG serostatus and outcome in recurrent longitudinally extensive transverse myelitis. JAMA Neurol. 2014;71:48–54.
Kitley J, Waters P, Woodhall M, et al. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol. 2014;71:276–83.
Palace J, Leite MI, Nairne A, Vincent A. Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers. Arch Neurol. 2010;67:1016–7.
Shimizu J, Hatanaka Y, Hasegawa M, et al. IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum. Neurology. 2010;75:1423–7.
Pittock SJ, Lennon VA, Bakshi N, et al. Seroprevalence of aquaporin-4-IgG in a northern California population representative cohort of multiple sclerosis. JAMA Neurol. 2014;71:1433–6.
Wingerchuk DM, Hogancamp WF, O’Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology. 1999;53:1107–14.
Wingerchuk DM, Weinshenker BG. Neuromyelitis optica: clinical predictors of a relapsing course and survival. Neurology. 2003;60:848–53.
Matiello M, Lennon VA, Jacob A, et al. NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology. 2008;70:2197–200.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Italia
About this chapter
Cite this chapter
Filippini, G. (2015). Myelin Disorders: Devic’s Syndrome. In: Sghirlanzoni, A., Lauria, G., Chiapparini, L. (eds) Prognosis of Neurological Diseases. Springer, Milano. https://doi.org/10.1007/978-88-470-5755-5_12
Download citation
DOI: https://doi.org/10.1007/978-88-470-5755-5_12
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-5754-8
Online ISBN: 978-88-470-5755-5
eBook Packages: MedicineMedicine (R0)